NCT01993134

Brief Summary

The study set out to evaluate the efficacy of two antibiotic prophylaxis regimens in patients with facial fractures admitted to the Oral and Maxillofacial Surgery and Traumatology services of the Onofre Lopes University Hospital attached to the Federal University of Rio Grande do Norte.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
75

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Dec 2011

Typical duration for phase_2

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2011

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2013

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

November 11, 2013

Completed
14 days until next milestone

First Posted

Study publicly available on registry

November 25, 2013

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
Last Updated

November 25, 2013

Status Verified

November 1, 2013

Enrollment Period

1.9 years

First QC Date

November 11, 2013

Last Update Submit

November 18, 2013

Conditions

Keywords

Postoperative infectionAntibiotic prophylaxisCefazolin

Outcome Measures

Primary Outcomes (1)

  • Reduction of postoperative infection

    Post-operative follow up was conducted in the 1st, 2nd, 4th and 6th weeks. The criteria used to determine the presence of infection were: a) pus drainage at the fracture site or in the vicinity of the surgical intervention site; b) increased swelling 7 days after the operation; c) presence of a fistula in the area of the surgical intervention or at the site of the fracture, with active drainage; d) other clinical features observed by the evaluator including typical signs of infection such as fever, edema, and localized redness.

    45 days

Study Arms (2)

Cefazolin

EXPERIMENTAL

2g of Cefazolin, 20minutes before sugery. After surgery, 1g of cefazolin 06/06h.

Procedure: Cefazolin

Cefazolin Single Dose

ACTIVE COMPARATOR

2g of Cefazolin, 20minutes before sugery. After surgery, no drugs.

Procedure: Cefazolin Single Dose

Interventions

CefazolinPROCEDURE

Cefazolin, 2g/IV, prior to surgery, and after surgery recieved 4 aditional doses 1g/IV of Cefazolin.

Cefazolin

Patients received 2g of Cefazolin (Cefazolin Sodium - Ampoule- 1g - Genéricos Brasil), administered intravenously but none was administered in the post-operative period

Cefazolin Single Dose

Eligibility Criteria

Age15 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Both genders
  • ASA I, II, III
  • have facial fractures, that request surgical treatement, and whitout infection

You may not qualify if:

  • Patients with pan-facial fractures
  • Or requiring surgery longer than six hours

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oral and Maxillofacial Surgery and Traumatology services of the Onofre Lopes University Hospital

Natal, Rio Grande do Norte, 59012-300, Brazil

RECRUITING

MeSH Terms

Interventions

Cefazolin

Intervention Hierarchy (Ancestors)

Cephalosporinsbeta-LactamsLactamsAmidesOrganic ChemicalsThiazinesSulfur CompoundsHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic Compounds

Study Officials

  • Adriano Germano, PhD

    Universidade Federal do Rio Grande do Norte

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
DDS

Study Record Dates

First Submitted

November 11, 2013

First Posted

November 25, 2013

Study Start

December 1, 2011

Primary Completion

November 1, 2013

Study Completion

December 1, 2014

Last Updated

November 25, 2013

Record last verified: 2013-11

Locations